About FDA
Percentage of NDI notification reviews completed during the month within 75 days of filing
Dictionary: Timely review of notifications of new dietary ingredients impacts the public health by preventing substances that are not actually dietary ingredients from being used in dietary supplements, and assuring that new dietary ingredients have adequate evidence for presumption of safety. Since these statutory requirements are notifications rather than pre-market approvals, it is essential that ONLDS have completed review of the information before the submitter markets the product, to notify them of any safety or regulatory concerns before the product reaches consumers.
Information is current as of December 31, 2012.
Fiscal Year - 2010
| Time | Annual Target | Percentage |
|---|---|---|
| Oct 2009 | 90 | 100 |
| Nov 2009 | 90 | 75 |
| Dec 2009 | 90 | 100 |
| Jan 2010 | 90 | 100 |
| Feb 2010 | 90 | 100 |
| Mar 2010 | 90 | 100 |
| Apr 2010 | 90 | 100 |
| May 2010 | 90 | 86 |
| Jun 2010 | 90 | 80 |
| Jul 2010 | 90 | 80 |
| Aug 2010 | 90 | 100 |
| Sep 2010 | 90 | N/A |
FY 2010 Overall: 91%
Number of NDI notification reviews completed during the month within 75 days of filing
Fiscal Year - 2010
| Time | Target | Number |
|---|---|---|
| Oct 2009 | N/A | 4 |
| Nov 2009 | N/A | 3 |
| Dec 2009 | N/A | 2 |
| Jan 2010 | N/A | 2 |
| Feb 2010 | N/A | 3 |
| Mar 2010 | N/A | 6 |
| Apr 2010 | N/A | 4 |
| May 2010 | N/A | 6 |
| Jun 2010 | N/A | 4 |
| Jul 2010 | N/A | 4 |
| Aug 2010 | N/A | 3 |
| Sep 2010 | N/A | 0 |
FY 2010 Total: 41
Total number of NDI notification reviews completed during the month
Fiscal Year - 2010
| Time | Target | Number |
|---|---|---|
| Oct 2009 | N/A | 4 |
| Nov 2009 | N/A | 4 |
| Dec 2009 | N/A | 2 |
| Jan 2010 | N/A | 2 |
| Feb 2010 | N/A | 3 |
| Mar 2010 | N/A | 6 |
| Apr 2010 | N/A | 4 |
| May 2010 | N/A | 7 |
| Jun 2010 | N/A | 5 |
| Jul 2010 | N/A | 5 |
| Aug 2010 | N/A | 3 |
| Sep 2010 | N/A | 0 |
FY 2010 Total: 45
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
